📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis. (2018)

First Author: Arthur VL

Attributed to: MICA: Childhood Arthritis Response to Treatment consortium - partnership to define stratified medicine tools for childhood inflammatory arthritis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/art.40498

PubMed Identifier: 29609200

Publication URI: http://europepmc.org/abstract/MED/29609200

Type: Journal Article/Review

Volume: 70

Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)

Issue: 8

ISSN: 2326-5191